This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative |
Raw XML (canonical form + also see XML Format Specification)
Definition for Code SystemProductContactType
<?xml version="1.0" encoding="UTF-8"?> <CodeSystem xmlns="http://hl7.org/fhir"> <id value="medicinal-product-contact-type"/> <meta> <lastUpdated value="2023-03-26T15:21:02.749+11:00"/> <profile value="http://hl7.org/fhir/StructureDefinition/shareablecodesystem"/> </meta> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p> This code system <code> http://hl7.org/fhir/medicinal-product-contact-type</code> defines the following codes: </p> <table class="codes"> <tr> <td style="white-space:nowrap"> <b> Code</b> </td> <td> <b> Display</b> </td> <td> <b> Definition</b> </td> </tr> <tr> <td style="white-space:nowrap">ProposedMAH <a name="medicinal-product-contact-type-ProposedMAH"> </a> </td> <td> Proposed Marketing Authorization Holder/Person</td> <td> Proposed Marketing Authorization Holder/Person</td> </tr> <tr> <td style="white-space:nowrap">ProcedureContactDuring <a name="medicinal-product-contact-type-ProcedureContactDuring"> </a> </td> <td> Person/Company authorised for Communication during procedure</td> <td> Person/Company authorised for Communication on behalf of the Applicant during the Procedure</td> </tr> <tr> <td style="white-space:nowrap">ProcedureContactAfter <a name="medicinal-product-contact-type-ProcedureContactAfter"> </a> </td> <td> Person/Company authorised for Communication after procedure</td> <td> Person/Company authorised for Communication between MAH and Authorities after Authorization</td> </tr> <tr> <td style="white-space:nowrap">QPPV <a name="medicinal-product-contact-type-QPPV"> </a> </td> <td> Qualified Person Responsible for Pharmacovigilance</td> <td> Qualified Person Responsible for Pharmacovigilance</td> </tr> <tr> <td style="white-space:nowrap">PVEnquiries <a name="medicinal-product-contact-type-PVEnquiries"> </a> </td> <td> Pharmacovigilance Enquiry Information</td> <td> Pharmacovigilance Enquiry Information</td> </tr> </table> </div> </text> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"> <valueCode value="brr"/> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status"> <valueCode value="trial-use"/> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"> <valueInteger value="1"/> </extension> <url value="http://hl7.org/fhir/medicinal-product-contact-type"/> <identifier> <system value="urn:ietf:rfc:3986"/> <value value="urn:oid:2.16.840.1.113883.4.642.4.1925"/> </identifier> <version value="5.0.0"/> <name value="ProductContactType"/> <title value="Product Contact Type"/> <status value="active"/> <experimental value="false"/> <date value="2021-01-05T10:01:24+11:00"/> <publisher value="HL7 (FHIR Project)"/> <contact> <telecom> <system value="url"/> <value value="http://hl7.org/fhir"/> </telecom> <telecom> <system value="email"/> <value value="fhir@lists.hl7.org"/> </telecom> </contact> <description value="Contact type for a Medicinal Product."/> <jurisdiction> <coding> <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/> <code value="001"/> <display value="World"/> </coding> </jurisdiction> <caseSensitive value="true"/> <valueSet value="http://hl7.org/fhir/ValueSet/medicinal-product-contact-type"/> <content value="complete"/> <concept> <code value="ProposedMAH"/> <display value="Proposed Marketing Authorization Holder/Person"/> <definition value="Proposed Marketing Authorization Holder/Person"/> </concept> <concept> <code value="ProcedureContactDuring"/> <display value="Person/Company authorised for Communication during procedure"/> <definition value="Person/Company authorised for Communication on behalf of the Applicant during the Procedure"/> </concept> <concept> <code value="ProcedureContactAfter"/> <display value="Person/Company authorised for Communication after procedure"/> <definition value="Person/Company authorised for Communication between MAH and Authorities after Authorization"/> </concept> <concept> <code value="QPPV"/> <display value="Qualified Person Responsible for Pharmacovigilance"/> <definition value="Qualified Person Responsible for Pharmacovigilance"/> </concept> <concept> <code value="PVEnquiries"/> <display value="Pharmacovigilance Enquiry Information"/> <definition value="Pharmacovigilance Enquiry Information"/> </concept> </CodeSystem>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R5 hl7.fhir.core#5.0.0 generated on Sun, Mar 26, 2023 15:22+1100.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4 |
Compare to R4B |
|
Propose a change